Skip to content

Welcome to Discover Pharma! Today is : October 28, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Uncategorised

  • Uncategorised

    Actithera raises $75.5M to advance precision radioligand therapies targeting difficult-to-drug tumors

    Oversubscribed Series A financing led by M Ventures, Hadean, Sofinnova [...]

    July 9, 2025
  • Uncategorised

    ten23 health joins Alliance for RTU to advance sterile manufacturing standards

    ten23 health has joined the Alliance for RTU, a technical [...]

    June 30, 2025
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Uncategorised

    Veeva unveils bold vision for simplifying, standardising, and AI-powered innovation

    In a keynote address that signaled both reflection and momentum, [...]

    May 5, 2026
  • Uncategorised

    Selvita licenses Medicines Discovery Catapult’s target engagement technology

    Selvita has become the first contract research organisation (CRO) to [...]

    May 29, 2025
  • Drug Discovery & Development,Opinion & Events,Uncategorised

    SpotitEarly targets US market with AI-canine breath test for early cancer detection

    A biotech company combining artificial intelligence with canine scent detection [...]

    May 5, 2026
Previous12

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Nabsys launches RepX for repeat expansion analysis
    Categories: Genomics and sequencing
  • NICE recommends maralixibat for Alagille syndrome itching
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Mursla Bio validates liver-specific liquid biopsy platform
    Categories: Clinical & Regulatory, Genomics and sequencing, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top